Ocugen Chairman, CEO & Co-founder, Dr. Shankar Musunuri, to Speak During U.S.-India Initiative on Critical and Emerging Technology Workshop

Core Insights - Ocugen, Inc. is participating in a workshop titled "U.S.-India Biotechnology Cooperation: Realizing Benefits, Reducing Risks" from September 9-11, 2024, in New Delhi, India, with Dr. Shankar Musunuri representing the company [1][2] - The workshop aims to explore opportunities for U.S.-India biotechnology collaboration, aligning with the initiative on Critical and Emerging Technology (iCET) [2] - Ocugen has established a site in Hyderabad, India, to enhance collaboration in the biotechnology sector [2] Company Overview - Ocugen, Inc. focuses on discovering, developing, and commercializing novel gene and cell therapies, and vaccines aimed at improving global health [3] - The company is advancing a breakthrough modifier gene therapy platform that has the potential to treat multiple retinal diseases with a single product [3] - Ocugen is also conducting research in infectious diseases and orthopedic diseases to address unmet medical needs [3]